Endogenous antiangiogenic factors in chronic kidney disease

Potential biomarkers of progression

Katsuyuki Tanabe, Yasufumi Sato, Jun Wada

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD. Angiogenesis is involved in physiological and pathological processes in the kidney and is regulated by the balance between a proangiogenic factor, vascular endothelial growth factor (VEGF)-A, and various endogenous antiangiogenic factors. In recent reports using genetically engineered mice, the roles of these antiangiogenic factors in the pathogenesis of kidney disease have become increasingly clear. In addition, recent clinical studies have demonstrated associations between circulating levels of antiangiogenic factors and renal dysfunction in CKD patients. In this review, we summarize recent advances in the study of representative endogenous antiangiogenic factors, including soluble fms-related tyrosine kinase 1, soluble endoglin, pigment epithelium-derived factor, VEGF-A165 b, endostatin, and vasohibin-1, in associations with kidney diseases and discuss their predictive potentials as biomarkers of progression of CKD.

Original languageEnglish
Article number1859
JournalInternational Journal of Molecular Sciences
Volume19
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

kidney diseases
biomarkers
Biomarkers
Chronic Renal Insufficiency
progressions
Kidney Diseases
Kidney
Vascular Endothelial Growth Factor A
Endostatins
Physiological Phenomena
Pathologic Processes
Protein-Tyrosine Kinases
Chronic Kidney Failure
angiogenesis
pathogenesis
Research Personnel
epithelium
tyrosine
kidneys
Medical problems

Keywords

  • Chronic kidney disease
  • Endogenous antiangiogenic factors
  • Endostatin
  • PEDF
  • Soluble Flt-1
  • Vasohibins
  • VEGF-A
  • VEGF-A b

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Endogenous antiangiogenic factors in chronic kidney disease : Potential biomarkers of progression. / Tanabe, Katsuyuki; Sato, Yasufumi; Wada, Jun.

In: International Journal of Molecular Sciences, Vol. 19, No. 7, 1859, 01.07.2018.

Research output: Contribution to journalReview article

@article{1f1439396a5a4a51a29fdb0574f6b386,
title = "Endogenous antiangiogenic factors in chronic kidney disease: Potential biomarkers of progression",
abstract = "Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD. Angiogenesis is involved in physiological and pathological processes in the kidney and is regulated by the balance between a proangiogenic factor, vascular endothelial growth factor (VEGF)-A, and various endogenous antiangiogenic factors. In recent reports using genetically engineered mice, the roles of these antiangiogenic factors in the pathogenesis of kidney disease have become increasingly clear. In addition, recent clinical studies have demonstrated associations between circulating levels of antiangiogenic factors and renal dysfunction in CKD patients. In this review, we summarize recent advances in the study of representative endogenous antiangiogenic factors, including soluble fms-related tyrosine kinase 1, soluble endoglin, pigment epithelium-derived factor, VEGF-A165 b, endostatin, and vasohibin-1, in associations with kidney diseases and discuss their predictive potentials as biomarkers of progression of CKD.",
keywords = "Chronic kidney disease, Endogenous antiangiogenic factors, Endostatin, PEDF, Soluble Flt-1, Vasohibins, VEGF-A, VEGF-A b",
author = "Katsuyuki Tanabe and Yasufumi Sato and Jun Wada",
year = "2018",
month = "7",
day = "1",
doi = "10.3390/ijms19071859",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",

}

TY - JOUR

T1 - Endogenous antiangiogenic factors in chronic kidney disease

T2 - Potential biomarkers of progression

AU - Tanabe, Katsuyuki

AU - Sato, Yasufumi

AU - Wada, Jun

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD. Angiogenesis is involved in physiological and pathological processes in the kidney and is regulated by the balance between a proangiogenic factor, vascular endothelial growth factor (VEGF)-A, and various endogenous antiangiogenic factors. In recent reports using genetically engineered mice, the roles of these antiangiogenic factors in the pathogenesis of kidney disease have become increasingly clear. In addition, recent clinical studies have demonstrated associations between circulating levels of antiangiogenic factors and renal dysfunction in CKD patients. In this review, we summarize recent advances in the study of representative endogenous antiangiogenic factors, including soluble fms-related tyrosine kinase 1, soluble endoglin, pigment epithelium-derived factor, VEGF-A165 b, endostatin, and vasohibin-1, in associations with kidney diseases and discuss their predictive potentials as biomarkers of progression of CKD.

AB - Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD. Angiogenesis is involved in physiological and pathological processes in the kidney and is regulated by the balance between a proangiogenic factor, vascular endothelial growth factor (VEGF)-A, and various endogenous antiangiogenic factors. In recent reports using genetically engineered mice, the roles of these antiangiogenic factors in the pathogenesis of kidney disease have become increasingly clear. In addition, recent clinical studies have demonstrated associations between circulating levels of antiangiogenic factors and renal dysfunction in CKD patients. In this review, we summarize recent advances in the study of representative endogenous antiangiogenic factors, including soluble fms-related tyrosine kinase 1, soluble endoglin, pigment epithelium-derived factor, VEGF-A165 b, endostatin, and vasohibin-1, in associations with kidney diseases and discuss their predictive potentials as biomarkers of progression of CKD.

KW - Chronic kidney disease

KW - Endogenous antiangiogenic factors

KW - Endostatin

KW - PEDF

KW - Soluble Flt-1

KW - Vasohibins

KW - VEGF-A

KW - VEGF-A b

UR - http://www.scopus.com/inward/record.url?scp=85049070556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049070556&partnerID=8YFLogxK

U2 - 10.3390/ijms19071859

DO - 10.3390/ijms19071859

M3 - Review article

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 7

M1 - 1859

ER -